Get the Stockscreener App
1.51
1.34%
0.02
Accuray Inc stock is traded at $1.51, with a volume of 572.13K.
It is up +1.34% in the last 24 hours and down -5.03% over the past month.
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.
See More
Previous Close:
$1.49
Open:
$1.49
24h Volume:
572.13K
Relative Volume:
0.84
Market Cap:
$140.61M
Revenue:
$447.48M
Net Income/Loss:
$-14.55M
P/E Ratio:
-10.07
EPS:
-0.15
Net Cash Flow:
$7.61M
1W Performance:
+10.62%
1M Performance:
-5.03%
6M Performance:
-29.77%
1Y Performance:
-10.65%
1-Day Range:
$1.475
$1.54
1-Week Range:
$1.28
$1.54
52-Week Range:
$1.28
$2.95
Accuray Inc Stock (ARAY) Company Profile
Name
Accuray Inc
Sector
Industry
Phone
608-824-2800
Address
1240 DEMING WAY, MADISON, CA
Compare ARAY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ARAY
Accuray Inc
|
1.51 | 140.61M | 447.48M | -14.55M | 7.61M | -0.15 |
|
ABT
Abbott Laboratories
|
133.24 | 231.09B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.86 | 155.24B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.92 | 144.54B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.48 | 108.82B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.68 | 44.31B | 5.54B | 4.18B | 623.10M | 7.00 |
Accuray Inc Stock (ARAY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-13-24 | Initiated | ROTH MKM | Buy |
| Jun-23-22 | Initiated | B. Riley Securities | Buy |
| Dec-22-21 | Initiated | Loop Capital | Buy |
| Jan-21-20 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-01-18 | Upgrade | Citigroup | Sell → Neutral |
| Dec-13-17 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-30-17 | Initiated | Lake Street | Buy |
| Dec-14-16 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-22-15 | Initiated | RBC Capital Mkts | Sector Perform |
| Nov-12-15 | Initiated | Citigroup | Sell |
| May-01-15 | Reiterated | Dougherty & Company | Buy |
| Jan-12-15 | Initiated | Northland Capital | Outperform |
| Jan-31-14 | Reiterated | Dougherty & Company | Buy |
| Jan-29-14 | Reiterated | Brean Capital | Buy |
| Nov-11-13 | Reiterated | Dougherty & Company | Buy |
| Aug-29-13 | Reiterated | Dougherty & Company | Buy |
| Sep-20-11 | Reiterated | Ticonderoga | Buy |
| Feb-08-10 | Upgrade | Jefferies & Co | Hold → Buy |
| Dec-09-09 | Upgrade | UBS | Sell → Neutral |
| Mar-09-09 | Downgrade | Soleil | Buy → Hold |
| Jan-30-09 | Upgrade | Piper Jaffray | Neutral → Buy |
| Dec-22-08 | Reiterated | Jefferies & Co | Hold |
| Aug-20-08 | Reiterated | Jefferies & Co | Hold |
View All
Accuray Inc Stock (ARAY) Latest News
Accuray Third Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Accuray Presents New Data Showing Benefits Of Robotic Radiotherapy Device CyberKnife At ESTRO - Nasdaq
Accuray Showcases New Long-Term Data¹ on Benefits of 5 Session Radiotherapy Treatment for Men with Prostate Cancer at ESTRO 2025 | ARAY Stock News - GuruFocus
Accuray Showcases New Long-Term Data¹ on Benefits of 5 Session Radiotherapy Treatment for Men with Prostate Cancer at ESTRO 2025 - Stock Titan
ARAY: Accuray's CyberKnife System Debuts in Austria | ARAY Stock News - GuruFocus
Accuray Announces First SRS/SBRT Patient Treatments in Austria With the CyberKnife® System - PR Newswire
Equities Analysts Offer Predictions for Accuray Q4 Earnings - Defense World
Accuray Incorporated (NASDAQ:ARAY) Shares Bought by Wells Fargo & Company MN - Defense World
Roth Capital Estimates Accuray’s Q1 Earnings (NASDAQ:ARAY) - The AM Reporter
ACCURAY INC SEC 10-Q Report - TradingView
Accuray Incorporated (NASDAQ:ARAY) Q3 2025 Earnings Call Transcript - Insider Monkey
Accuray Incorporated (NASDAQ:ARAY) Delivered A Weaker ROE Than Its Industry - Yahoo Finance
ARAY’s Market Whiplash: -29.80% YTD Decline, -21.91% Plunge in 30 Days - investchronicle.com
Should investors be concerned about ARAY’s high price-to-sales ratio? - uspostnews.com
ARAY Stock Down Despite Q3 Earnings Beat Estimates, Revenues Up Y/Y - Barchart.com
Accuray Inc [ARAY] Shares Fall -4.32 % on Wednesday - knoxdaily.com
Ready to Jump After Recent Trade: Accuray Inc (ARAY) - Sete News
Accuray (ARAY) Exceeds Q3 Revenue Expectations with Strong Perfo - GuruFocus
Accuray Reports Fiscal 2025 Third Quarter Financial Results | AR - GuruFocus
JPMorgan Chase & Co. Has $481,000 Stake in Accuray Incorporated (NASDAQ:ARAY) - Defense World
Accuray Inc (ARAY) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Global Challenges - Yahoo Finance
Accuray: Fiscal Q3 Earnings Snapshot - CT Insider
Accuray Inc (ARAY) Q3 2025 Earnings Call Highlights: Strong Reve - GuruFocus
Accuray Inc (ARAY) Q3 Earnings: EPS of -$0.01 Beats Estimates, R - GuruFocus
Accuray earnings beat by $0.02, revenue topped estimates - Investing.com
Accuray (ARAY) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Accuray Q3 FY25 presentation: revenue jumps 12%, guidance revised downward - Investing.com
Accuray Reports Fiscal 2025 Third Quarter Financial Results - PR Newswire
Pancreatic Cancer Market Set to Witness Significant Growth - openPR.com
Medical Devices Market Is Booming So Rapidly | Fresenius, Johnson & Johnson, Accuray - openPR.com
XTX Topco Ltd Trims Stake in Accuray Incorporated (NASDAQ:ARAY) - Defense World
Accuray Incorporated (NASDAQ:ARAY) Shares Purchased by Geode Capital Management LLC - Defense World
Stock Market Recap: Accuray Inc (ARAY) Concludes at 1.51, a 3.42 Surge/Decline - DWinneX
Healthcare Robotics Market Next Big Thing: Major Giants- Hocoma, Toyota, Accuray - newstrail.com
Accuray to Report Third Quarter Fiscal 2025 Financial Results on April 30, 2025 | ARAY Stock News - GuruFocus
Accuray to Report Third Quarter Fiscal 2025 Financial Results on April 30, 2025 - Yahoo Finance
Philippines Radiotherapy Market Deep Research Report with - openPR.com
Sei Investments Co. Has $65,000 Holdings in Accuray Incorporated (NASDAQ:ARAY) - Defense World
StockNews.com Upgrades Accuray (NASDAQ:ARAY) to Buy - Defense World
ARAY Stock Gains as China Approves Latest Radiation Therapy Solutions - MSN
Prudential Financial Inc. Takes Position in Accuray Incorporated (NASDAQ:ARAY) - Defense World
Study Shows Cyberknife System Beneficial for Treating CNS Tumors - Imaging Technology News
Here's Why You Should Hold Accuray Stock in Your Portfolio for Now - Yahoo Finance
Accuray CyberKnife® Platform Featured in New Studies Showcasing its Benefits in Central Nervous System Tumors Presented at Radiosurgery Society Scientific Meeting - MarketScreener
Breakthrough 25-Year Study Reveals CyberKnife's 89% Cancer Treatment Success - Stock Titan
Biotricity (NASDAQ:BTCY) & Accuray (NASDAQ:ARAY) Financial Review - The AM Reporter
Accuray Incorporated (NASDAQ:ARAY): When Will It Breakeven? - Yahoo Finance
Connor Clark & Lunn Investment Management Ltd. Raises Stock Position in Accuray Incorporated (NASDAQ:ARAY) - Defense World
Accuray (NASDAQ:ARAY) Upgraded at StockNews.com - Defense World
Accuray (NASDAQ:ARAY) Is Experiencing Growth In Returns On Capital - Yahoo Finance
Accuray to Participate at 37th Annual Roth Conference - PR Newswire
Accuray Inc Stock (ARAY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Accuray Inc Stock (ARAY) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Pervaiz Ali | SVP Chief Financial Officer |
Sep 04 '24 |
Sale |
2.06 |
8,404 |
17,276 |
394,138 |
| Pervaiz Ali | SVP Chief Financial Officer |
Jun 04 '24 |
Sale |
1.70 |
2,701 |
4,597 |
402,542 |
| WHITTERS JOSEPH E | Director |
May 29 '24 |
Buy |
1.58 |
50,000 |
79,000 |
561,053 |
| WHITTERS JOSEPH E | Director |
May 28 '24 |
Buy |
1.54 |
50,000 |
77,045 |
511,053 |
0.11%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):